June 22 (Reuters) - The U.S. Food and Drug Administration said on Monday it is launching a series of measures to speed up ...
The US Food and Drug Administration (FDA) has revised a 2023 draft guidance on master protocols for drug and biological ...
FDA revised guidance documents for low-risk wellness products and clinical decision software, clarifying regulatory ...
The US Food and Drug Administration has updated its draft guidance on how the drug and medical device makers should communicate with payors and other stakeholders about their products. The updates are ...
The FDA's new rules mean you can no longer just submit basic health data codes, since the most critical patient details are ...
This is part two of a two-part article offering proposals to improve the FDA’s draft guidance to implement a new approval ...
FDA’s draft “plausible mechanism” framework gives individualized genetic therapies a clearer path to market, but questions remain, write experts at Morrison Foerster.
FDA’s recently unveiled 2025 Human Foods Program guidance agenda offers a detailed view of the agency’s priorities for the year ahead. The document is non-binding, but provides critical insight into ...
Recent changes in CDC and FDA guidelines for COVID vaccinations have led to confusion over insurance coverage, especially for those without high-risk conditions.As children return to school and colder ...
Please provide your email address to receive an email when new articles are posted on . The FDA frequently identifies uncertainties about newly approved cancer drugs, but they are often omitted in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results